Abstract
The impact of diabetes on health care expenditures has been increasingly recognized. Number of ‘cost of illness’ studies has shown a threefold increase in the direct costs of diabetic patients compared with non-diabetic patients. This study aimed to evaluate the prescription patterns and cost of illness of type II diabetic patients along with the trends in anti-diabetic and antihypertensive drug use patterns among patients with type II diabetes patients with and without comorbidities.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
